Company Final Prospectus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Company final prospectus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Company Final Prospectus Today - Breaking & Trending Today

Optimi Health Announces DTC Eligibility & Up-List to OTCQB


VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE)
Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that its US-based OTC Markets listing under the symbol “OPTHF” has received approval from the Depository Trust Company (“DTC”) to make the Company’s common shares eligible to be electronically cleared and settled through DTC (“DTC Eligibility”).
DTC is a subsidiary of the Depository Trust and Clearing Corporation, a United States company that manages the electronic clearing and settlement of publicly traded companies. DTC Eligibility incorporates an electronic method of clearing securities that speeds up the receipt of stock and cash, and thus accelerates the settlement process for certain investors. DTC is a member of the U.S. Federal Reserve System, a limited-purpose trust com ....

New York , United States , United Kingdom , British Columbia , Michael Stier , Mike Stier , Clearing Corporation , Health Canada Food , Optimi Labs Inc , Group Inc , Exchange Commission , Company Final Prospectus , Canadian Securities Exchange , Optimi Health Corp , Optimi Health , Depository Trust Company , Depository Trust , Reserve System , New York State , United States Securities , Chief Executive Officer , Drug Regulations , Optimi Labs , Narcotic Control Regulations , Final Prospectus , புதியது யார்க் ,

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch


VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE)
Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce it has received product licensing paving the way for the commencement of nutraceutical marketing and sales in Q2, 2021.
Optimi Health is developing an innovative pipeline of functional, medicinal, and nutraceutical mushroom brands encompassing natural health products to proposed, future psychedelic formulations. In preparation for the public sales launch of its nutraceutical brand lineup, the Company applied for and has now received NPN licenses for six products. These include five singular mushroom strain capsules (Reishi, Chaga, Turkey Tail, Lions Mane and Cordyceps) and one proprietary Optimi formulated mixed blend capsule. To sell natural health products in Canada, companies must obtain a product license call ....

United States , United Kingdom , British Columbia , Odane Stevens , Khloe Kardashian , Mike Stier , Harley Pasternak , Prescription Health Product Directorate , Health Canada Food , American College Of Sports Medicine , University Of Western Ontario , Optimi Health , Optimi Labs Inc , University Of Toronto , Nutritional Sciences , Company Final Prospectus , Canadian Society Of Exercise Physiology , Health Canada , Canada Department Of National Defense , Optimi Health Corp , Turkey Tail , Lions Mane , Natural Product Number , Non Prescription Health Product Directorate , Optimi Board Chair , Revenge Body ,